Mechanistically, the expression of RP11 is upregulated in an m6A modification-dependent manner; then, the complex composed by RP11 and HNRNPA2B1 prevents Zeb1 degradation, triggering the dissemination of cancer cells (Wu et al., 2019). Here, HNRNPA2B1 is linked to cancer.